Geoffrey M Duyk has an estimated net worth of $1.94 Million. This is based on reported shares across multiple companies, which include AMYRIS, INC., EXELIXIS INC, AERIE PHARMACEUTICALS INC, REPLIDYNE INC, and EPIRUS Biopharmaceuticals, Inc..

2003 was Geoffrey M Duyk's most active year for acquiring shares with 5 total transactions. Geoffrey M Duyk's most active month to acquire stocks was the month of July. 2017 was Geoffrey M Duyk's most active year for disposing of shares, totalling 10 transactions. Geoffrey M Duyk's most active month to dispose stocks was the month of January. 2017 saw Geoffrey M Duyk paying a total of $778,131.50 for 58,167 shares, this is the most they've acquired in one year. In 2017 Geoffrey M Duyk cashed out on 116,334 shares for a total of $2,717,739.84, their largest year based on trade value.